Journal of Cancer Metastasis and Treatment Receives an Impact Factor of 1.6 in 2025 JCR

Clarivate released the 2025 Journal Citation Reports (JCR) on June 17, 2026. We are pleased to announce that Journal of Cancer Metastasis and Treatment (JCMT) has received a Journal Impact Factor of 1.6 in the 2025 JCR. In the Oncology category, JCMT is ranked 280th among 333 journals and is listed in Q4.

We would like to express our sincere gratitude to our Editorial Board members, Guest Editors, authors, reviewers, and readers worldwide for their steadfast support and invaluable contributions.

JCMT remains committed to serving as an open-access platform for disseminating innovative research in cancer metastasis and treatment. Looking ahead, we welcome outstanding submissions from researchers worldwide and seek to foster meaningful contributions in advancing oncology research.

Editor: Frida Tian
Language Editor: Amir Khan
Production Editor: Ting Xu
Respectfully Submitted by the Editorial Office of Journal of Cancer Metastasis and Treatment